Oct 16, 2026 11:49AM
Oct 16, 2026 11:49AM
Oct 15, 2026 06:57AM
Oct 14, 2026 04:18PM
Oct 14, 2026 11:20AM
Oct 8, 2026 08:30AM
Oct 2, 2026 11:44AM These High-Voltage Stocks Are Suddenly Impossible to Ignore
Sep 14, 2026 10:30AM
Sep 14, 2026 10:30AM
Sep 1, 2026 09:07AM
Aug 10, 2026 09:01AM
Aug 10, 2026 09:00AM
Aug 4, 2026 07:30AM
Jul 30, 2026 04:53AM UAE approves ImmunityBio's Anktiva for bladder and lung cancer
Jul 29, 2026 06:45PM
Jun 1, 2026 01:53PM
Jun 1, 2026 01:51PM
May 21, 2026 04:28PM
May 20, 2026 02:18PM
May 19, 2026 08:30PM
May 19, 2026 08:30PM ImmunityBio Announces FDA Acceptance of Supplemental BLA for ANKTIVA® Plus BCG in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Papillary Disease; PDUFA Date Set for January 6, 2027
May 19, 2026 02:16PM
May 19, 2026 07:31AM
May 19, 2026 07:30AM
May 18, 2026 01:01PM
May 18, 2026 07:31AM
May 18, 2026 07:30AM
May 16, 2026 01:35PM ImmunityBio signs exclusive US deal for Tokyo BCG strain to address shortage
May 16, 2026 01:35PM
May 7, 2026 09:00AM
May 7, 2026 07:30AM
Apr 6, 2026 07:30AM
Apr 6, 2026 07:30AM
Mar 31, 2026 07:31AM
Mar 31, 2026 07:30AM ImmunityBio Strengthens Balance Sheet with $100 Million of Financing Transactions Including $75 Million of Non-Dilutive Financing to Support Global Expansion and Advancement of Broader Immunotherapy P
Mar 26, 2026 07:30AM
Mar 26, 2026 07:30AM
Mar 24, 2026 12:52PM
Mar 24, 2026 10:44AM
Mar 24, 2026 09:27AM
Mar 20, 2026 01:08PM
Mar 20, 2026 01:08PM ImmunityBio Announces Approval in Macau SAR, China for ANKTIVA® in BCG-Unresponsive NMIBC with CIS ± Papillary Tumors
Mar 17, 2026 07:31AM
Mar 17, 2026 07:30AM
Mar 9, 2026 07:31AM
Mar 9, 2026 07:30AM
Mar 4, 2026 07:54AM
Feb 26, 2026 07:31AM
Feb 26, 2026 07:30AM ImmunityBio Completes Enrollment in Pivotal Randomized Trial Evaluating ANKTIVA® Plus BCG Versus BCG Alone in BCG-Naïve Non-Muscle Invasive Bladder Cancer Carcinoma In Situ
Feb 23, 2026 04:15PM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All